Pink Sheet Sources Say Makary Knew of Plan to Push Out Marks

Apr 10
Apr 10, 2025

Shortly before Martin Makary, M.D., was sworn in as FDA commissioner on March 28, he was briefed on the plan to push out Center for Biologics Evaluation and Research (CBER) Director Peter Marks, M.D., Ph.D., the agency’s leader of vaccines and cell and gene therapy work, per a former agency official, the Pink Sheet reports.

The news likely will concern industry and other agency stakeholders, including lawmakers, who were banking on Makary trying to keep politics and anti-vaccine sentiment from higher up in the Trump administration out of the agency.
Read more
© 2025 MMIT

Sarah Karlin-Smith

Sarah is a senior writer with Pink Sheet and specializes in the policy and politics that affect the pharmaceutical industry. She covers the US Food and Drug Administration, Centers for Medicare and Medicaid Service and Congress and other parts of federal and state government. Her work explores how government policies influence how drugs are developed and approved, what diseases are prioritized by scientists, and who gets access to medicines and at what cost.